BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1592 related articles for article (PubMed ID: 23334414)

  • 1. A T-bet gradient controls the fate and function of CCR6-RORγt+ innate lymphoid cells.
    Klose CS; Kiss EA; Schwierzeck V; Ebert K; Hoyler T; d'Hargues Y; Göppert N; Croxford AL; Waisman A; Tanriver Y; Diefenbach A
    Nature; 2013 Feb; 494(7436):261-5. PubMed ID: 23334414
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identity, regulation and in vivo function of gut NKp46+RORγt+ and NKp46+RORγt- lymphoid cells.
    Reynders A; Yessaad N; Vu Manh TP; Dalod M; Fenis A; Aubry C; Nikitas G; Escalière B; Renauld JC; Dussurget O; Cossart P; Lecuit M; Vivier E; Tomasello E
    EMBO J; 2011 Jun; 30(14):2934-47. PubMed ID: 21685873
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lineage relationship analysis of RORgammat+ innate lymphoid cells.
    Sawa S; Cherrier M; Lochner M; Satoh-Takayama N; Fehling HJ; Langa F; Di Santo JP; Eberl G
    Science; 2010 Oct; 330(6004):665-9. PubMed ID: 20929731
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinct requirements for T-bet in gut innate lymphoid cells.
    Sciumé G; Hirahara K; Takahashi H; Laurence A; Villarino AV; Singleton KL; Spencer SP; Wilhelm C; Poholek AC; Vahedi G; Kanno Y; Belkaid Y; O'Shea JJ
    J Exp Med; 2012 Dec; 209(13):2331-8. PubMed ID: 23209316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cross-talk between RORγt+ innate lymphoid cells and intestinal macrophages induces mucosal IL-22 production in Crohn's disease.
    Mizuno S; Mikami Y; Kamada N; Handa T; Hayashi A; Sato T; Matsuoka K; Matano M; Ohta Y; Sugita A; Koganei K; Sahara R; Takazoe M; Hisamatsu T; Kanai T
    Inflamm Bowel Dis; 2014 Aug; 20(8):1426-34. PubMed ID: 24991784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microbial flora drives interleukin 22 production in intestinal NKp46+ cells that provide innate mucosal immune defense.
    Satoh-Takayama N; Vosshenrich CA; Lesjean-Pottier S; Sawa S; Lochner M; Rattis F; Mention JJ; Thiam K; Cerf-Bensussan N; Mandelboim O; Eberl G; Di Santo JP
    Immunity; 2008 Dec; 29(6):958-70. PubMed ID: 19084435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Innate lymphoid cells regulate CD4+ T-cell responses to intestinal commensal bacteria.
    Hepworth MR; Monticelli LA; Fung TC; Ziegler CG; Grunberg S; Sinha R; Mantegazza AR; Ma HL; Crawford A; Angelosanto JM; Wherry EJ; Koni PA; Bushman FD; Elson CO; Eberl G; Artis D; Sonnenberg GF
    Nature; 2013 Jun; 498(7452):113-7. PubMed ID: 23698371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Innate Lymphoid Cells and Intestinal Inflammatory Disorders.
    Zheng M; Zhu J
    Int J Mol Sci; 2022 Feb; 23(3):. PubMed ID: 35163778
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The transcription factor T-bet is essential for the development of NKp46+ innate lymphocytes via the Notch pathway.
    Rankin LC; Groom JR; Chopin M; Herold MJ; Walker JA; Mielke LA; McKenzie AN; Carotta S; Nutt SL; Belz GT
    Nat Immunol; 2013 Apr; 14(4):389-95. PubMed ID: 23455676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RORγt+ innate lymphoid cells regulate intestinal homeostasis by integrating negative signals from the symbiotic microbiota.
    Sawa S; Lochner M; Satoh-Takayama N; Dulauroy S; Bérard M; Kleinschek M; Cua D; Di Santo JP; Eberl G
    Nat Immunol; 2011 Apr; 12(4):320-6. PubMed ID: 21336274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isolation of NK cells and NK-like cells from the intestinal lamina propria.
    Sanos SL; Diefenbach A
    Methods Mol Biol; 2010; 612():505-17. PubMed ID: 20033661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thy1+ Sca1+ innate lymphoid cells infiltrate the CNS during autoimmune inflammation, but do not contribute to disease development.
    Mair F; Becher B
    Eur J Immunol; 2014 Jan; 44(1):37-45. PubMed ID: 24105463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human type 1 innate lymphoid cells accumulate in inflamed mucosal tissues.
    Bernink JH; Peters CP; Munneke M; te Velde AA; Meijer SL; Weijer K; Hreggvidsdottir HS; Heinsbroek SE; Legrand N; Buskens CJ; Bemelman WA; Mjösberg JM; Spits H
    Nat Immunol; 2013 Mar; 14(3):221-9. PubMed ID: 23334791
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aryl hydrocarbon receptor promotes RORγt⁺ group 3 ILCs and controls intestinal immunity and inflammation.
    Qiu J; Zhou L
    Semin Immunopathol; 2013 Nov; 35(6):657-70. PubMed ID: 23975386
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Group 3 innate lymphoid cells continuously require the transcription factor GATA-3 after commitment.
    Zhong C; Cui K; Wilhelm C; Hu G; Mao K; Belkaid Y; Zhao K; Zhu J
    Nat Immunol; 2016 Feb; 17(2):169-78. PubMed ID: 26595886
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NCR
    Mikami Y; Scarno G; Zitti B; Shih HY; Kanno Y; Santoni A; O'Shea JJ; Sciumè G
    Eur J Immunol; 2018 Jul; 48(7):1174-1180. PubMed ID: 29524223
    [TBL] [Abstract][Full Text] [Related]  

  • 17. c-Maf restrains T-bet-driven programming of CCR6-negative group 3 innate lymphoid cells.
    Tizian C; Lahmann A; Hölsken O; Cosovanu C; Kofoed-Branzk M; Heinrich F; Mashreghi MF; Kruglov A; Diefenbach A; Neumann C
    Elife; 2020 Feb; 9():. PubMed ID: 32039762
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protection by tyrosine kinase inhibitor, tyrphostin AG126, through the suppression of IL-17A, RORγt, and T-bet signaling, in the BTBR mouse model of autism.
    Ahmad SF; Ansari MA; Nadeem A; Bakheet SA; Alshammari MA; Attia SM
    Brain Res Bull; 2018 Sep; 142():328-337. PubMed ID: 30172736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TCF-1 controls ILC2 and NKp46+RORγt+ innate lymphocyte differentiation and protection in intestinal inflammation.
    Mielke LA; Groom JR; Rankin LC; Seillet C; Masson F; Putoczki T; Belz GT
    J Immunol; 2013 Oct; 191(8):4383-91. PubMed ID: 24038093
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Double deficiency for RORγt and T-bet drives Th2-mediated allograft rejection in mice.
    Sabet-Baktach M; Eggenhofer E; Rovira J; Renner P; Lantow M; Farkas SA; Malaisé M; Edtinger K; Shaotang Z; Koehl GE; Dahlke MH; Schlitt HJ; Geissler EK; Kroemer A
    J Immunol; 2013 Oct; 191(8):4440-6. PubMed ID: 24058178
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 80.